Ключевые слова:
ген, хронический миелолейкоз, полимеразная цепная реакция, анализ, больные.Библиографические ссылки
Савченко В.Г., Туркина А.Г., Зарицкий А.Ю. с соавт. Клинические рекомендации по диагностике и лечению хроническогомиелолейкоза. Клиническая онкогематология, 2017; 10(3): 294-316. http://bloodjournal.ru/wp-content/uploads/2017/09/2.pdf
Bryan T Ciccarelli1, Tinghui Hu1,Qing Wang2, Julia J Kim2, Ian P Whitehead3 et al. Examination of clinically-derived p210 BCR/ABL1 RhoGEF mutations in a murine bone marrow transplantation model of CMLDOI:10.1016/j.leukres.2020.106440
Cambier N., Renneville A., Cazaentre T. et al. JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloprolifera¬tivedisorders. Leukemia. 2008; 22(7): 1454-5. https://doi.org/10.1038/sj.leu.2405088.
HosseinAyatollahi1, Mohammad Reza Keramati1, Abbas Shirdel2, Mohammad Mehdi Kooshyar2 et al.BCR-ABL fusion genes and laboratory findings in patients with chronic myeloid leukemia in northeast Iran 2018 Winter; 9(1):65-70. doi: 10. 22088/cjim.9.1.65.
Samara Silveira da Cruz12,AlineDamasceno¬Seabra1, Lais Helena RescinhoMacambira1Chronic Myelogenous Leukemia with Double Philadelphia Chromosome and Coexpression of p210 and p190 Fusion Transcripts 2022 Mar 25;13(4): 580. doi: 10.3390/genes13040580.
Shady Adnan-Awad123, Daehong Kim12, Helena Hohtari12, Komal Kumar Javarappa4 et al. Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targetsDOI:10.1038/s41375-020-01082-4
Siricilla M., Nader K., Ferber A. A et al. Сase report of chronic myelogenous leukemia with JAK2- and BCR-ABL-positive mutation.Am J HematolOncol. 2017; 13(2).
Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H. et al. (Eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edition). IARC: Lyon, 2017.